H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 231 Citations 228,195 1,509 World Ranking 22 National Ranking 17

Research.com Recognitions

Awards & Achievements

2019 - Libin/AHFMR Prize in Cardiovascular Research

2016 - Member of the National Academy of Medicine (NAM)

2009 - Distinguished Scientist Award, American Heart Association

2004 - Distinguished Fellowship Award, American College of Cardiology (ACC)

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Myocardial infarction
  • Cardiology

His scientific interests lie mostly in Internal medicine, Cardiology, Myocardial infarction, Surgery and Coronary artery disease. His study in Randomized controlled trial, Angioplasty, Heart failure, Angina and Unstable angina is carried out as part of his Internal medicine studies. His Randomized controlled trial study deals with Clinical trial intersecting with Intensive care medicine.

His Angioplasty study which covers Anesthesia that intersects with Aspirin. His Surgery research includes themes of Stroke and Hazard ratio. Robert M. Califf has included themes like Artery, Diabetes mellitus, Stenosis, Disease and Prospective cohort study in his Coronary artery disease study.

His most cited work include:

  • ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina) (4506 citations)
  • An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. (3240 citations)
  • Evaluating the yield of medical tests (1826 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Internal medicine, Cardiology, Myocardial infarction, Surgery and Intensive care medicine. His work on Internal medicine deals in particular with Heart failure, Angioplasty, Coronary artery disease, Acute coronary syndrome and Randomized controlled trial. He regularly links together related areas like Stroke in his Myocardial infarction studies.

His studies in Surgery integrate themes in fields like Platelet aggregation inhibitor and Hazard ratio. The Intensive care medicine study combines topics in areas such as Clinical trial and Disease. His Streptokinase research integrates issues from Coronary arteries and Tissue plasminogen activator.

He most often published in these fields:

  • Internal medicine (69.04%)
  • Cardiology (58.44%)
  • Myocardial infarction (46.65%)

What were the highlights of his more recent work (between 2012-2021)?

  • Internal medicine (69.04%)
  • Cardiology (58.44%)
  • Clinical trial (14.27%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Cardiology, Clinical trial, Heart failure and Intensive care medicine are his primary areas of study. Internal medicine is closely attributed to Placebo in his study. His research investigates the connection with Cardiology and areas like Diabetes mellitus which intersect with concerns in Physical therapy.

His work carried out in the field of Heart failure brings together such families of science as Odds ratio, Blood pressure and Confidence interval. His study looks at the intersection of Intensive care medicine and topics like Randomized controlled trial with Evidence-based medicine. Robert M. Califf interconnects Coronary artery disease and Artery, Surgery in the investigation of issues within Myocardial infarction.

Between 2012 and 2021, his most popular works were:

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial (555 citations)
  • Extent, Location, and Clinical Significance of Non-Infarct-Related Coronary Artery Disease Among Patients With ST-Elevation Myocardial Infarction (159 citations)
  • Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis (135 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Myocardial infarction

His primary scientific interests are in Internal medicine, Clinical trial, Heart failure, Cardiology and Intensive care medicine. The study incorporates disciplines such as Placebo and Physical therapy in addition to Internal medicine. His Clinical trial study also includes

  • Collaboratory that connect with fields like Health care,
  • Management science which is related to area like Research design.

The various areas that Robert M. Califf examines in his Heart failure study include Interquartile range, Medicaid and Comorbidity. His Cardiology study frequently draws connections between adjacent fields such as Guideline. Robert M. Califf focuses mostly in the field of Myocardial infarction, narrowing it down to matters related to Coronary artery disease and, in some cases, Artery, Coronary artery bypass surgery and Surgery.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina)

Eugene Braunwald;Elliott M. Antman;John W. Beasley;Robert M. Califf.
Circulation (2000)

8018 Citations

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.

Maarten Simoons;Eric Topol;Robert Califf;Frans van de Werf.
The New England Journal of Medicine (1993)

5422 Citations

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary: A report of the American College of Cardiology/American Heart Aassociation task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients With atrial fibrillation)Guidelines for the Management of Patients With Atrial Fibrillation)

Jeffrey L. Anderson;Cynthia D. Adams;Elliott M. Antman;Charles R. Bridges.
Journal of the American College of Cardiology (2006)

4562 Citations

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article

Eugene Braunwald;Elliott M Antman;John W Beasley;Robert M Califf.
Circulation (2002)

2827 Citations

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction)

Jeffrey L. Anderson;Cynthia D. Adams;Elliott M. Antman;Charles R. Bridges.
Circulation (2007)

2791 Citations

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

Thomas J. Ryan;Elliott M. Antman;Neil H. Brooks;Robert M. Califf.
Journal of the American College of Cardiology (1996)

2440 Citations

Evaluating the yield of medical tests

Frank E. Harrell;Robert M. Califf;David B. Pryor;Kerry L. Lee.
JAMA (1982)

2250 Citations

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.

M. Cohen;C. Demers;E. P. Gurfinkel;A. G. G. Turpie.
The New England Journal of Medicine (1997)

2101 Citations

Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes: Phase Z of the A to Z Trial

James A de Lemos;Michael A. Blazing;Stephen D. Wiviott;Eldrin F. Lewis.
JAMA (2004)

1789 Citations

Regression modelling strategies for improved prognostic prediction.

Frank E. Harrell;Kerry L. Lee;Robert M. Califf;David B. Pryor.
Statistics in Medicine (1984)

1596 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Robert M. Califf

Christopher P. Cannon

Christopher P. Cannon

Brigham and Women's Hospital

Publications: 421

Deepak L. Bhatt

Deepak L. Bhatt

Brigham and Women's Hospital

Publications: 417

E. Magnus Ohman

E. Magnus Ohman

Duke University

Publications: 356

Eugene Braunwald

Eugene Braunwald

Harvard Medical School

Publications: 350

Roxana Mehran

Roxana Mehran

Icahn School of Medicine at Mount Sinai

Publications: 344

Harvey D. White

Harvey D. White

Auckland City Hospital

Publications: 339

Eric D. Peterson

Eric D. Peterson

Duke University

Publications: 329

Eric J. Topol

Eric J. Topol

Scripps Research Institute

Publications: 314

Gregg W. Stone

Gregg W. Stone

Columbia University Medical Center

Publications: 294

Matthew T. Roe

Matthew T. Roe

Duke University

Publications: 281

Harlan M. Krumholz

Harlan M. Krumholz

Yale University

Publications: 274

Christopher M. O'Connor

Christopher M. O'Connor

Duke University

Publications: 273

Christopher B. Granger

Christopher B. Granger

Duke University

Publications: 263

Elliott M. Antman

Elliott M. Antman

Brigham and Women's Hospital

Publications: 263

C. Michael Gibson

C. Michael Gibson

Beth Israel Deaconess Medical Center

Publications: 260

Something went wrong. Please try again later.